Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 17,751 | $117.26 | $2,081,482.26 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 15 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,641,226 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $116.50 to $117.475, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 30, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 25,000 | $117.00 | $2,925,000.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 14 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,658,977 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 30, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 12,537 | $115.72 | $1,450,781.64 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 13 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,683,977 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $115.50 to $116.45, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 30, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 50,000 | $115.00 | $5,750,000.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 12 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,696,514 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 29, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 175,000 | $113.57 | $19,874,750.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 11 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,746,514 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $113.25 to $114.00, inclusive. Read SEC document |
| May 29, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 95 | $115.50 | $10,972.50 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 10 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,514 Read SEC document |
| May 29, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 175,000 | $113.57 | $19,874,750.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 11 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,746,514 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $113.25 to $114.00, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 29, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 95 | $115.50 | $10,972.50 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 10 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,921,514 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 25, 2018 Filed May 26, 2018 00:30 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 100,000 | $115.00 | $11,500,000.00 |
DisclosureSEC source: 0001144204-18-031181 · tv495187_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,921,609 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| May 25, 2018 Filed May 26, 2018 00:28 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 100,000 | $115.00 | $11,500,000.00 |
DisclosureSEC source: 0001144204-18-031180 · tv495185_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,609 Read SEC document |
| May 23, 2018 Filed May 26, 2018 00:30 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,144 | $120.86 | $500,843.84 |
DisclosureSEC source: 0001144204-18-031181 · tv495187_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,021,609 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $120.61 to $120.91, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 23, 2018 Filed May 26, 2018 00:28 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,144 | $120.86 | $500,843.84 |
DisclosureSEC source: 0001144204-18-031180 · tv495185_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,021,609 F1 · price: Weighted average price. Price range in multiple transactions was $120.61 to $120.91, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:47 UTC |
Mulham David MulhamChief Field Development Office
|
Exercise / conversionStock - Settles Stock Appreciation Right · Derivative | 40,000 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-007122 · edgar.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 40,000 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:47 UTC |
Mulham David MulhamChief Field Development Office
|
SaleCommon Stock | 9,878 | $113.30 | $1,119,215.92 |
DisclosureSEC source: 0001179110-18-007122 · edgar.xml · nonDerivative · entry 3 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: Weighted average price $113.3039. Price range in multiple transactions was $113.10 to $113.55 inclusively. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:47 UTC |
Mulham David MulhamChief Field Development Office
|
SaleCommon Stock | 4,855 | $112.47 | $546,045.73 |
DisclosureSEC source: 0001179110-18-007122 · edgar.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,878 F2 · price: Weighted average price $112.4708. Price range in multiple transactions was $112.00 to $112.9501 inclusively. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:47 UTC |
Mulham David MulhamChief Field Development Office
|
Exercise / conversionCommon Stock | 14,733 | $70.75 | $1,042,286.09 |
DisclosureSEC source: 0001179110-18-007122 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| May 02, 2018 Filed May 3, 2018 20:29 UTC | SaleCommon Stock | 510 | $105.54 | $53,823.87 |
DisclosureSEC source: 0001179110-18-006163 · edgar.xml · nonDerivative · entry 3 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:30 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 40,000 | $105.96 | $4,238,492.00 |
DisclosureSEC source: 0001179110-18-006166 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,162,153 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $105.05 to $106.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:30 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 40,000 | $105.96 | $4,238,492.00 |
DisclosureSEC source: 0001179110-18-006165 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,162,153 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $105.05 to $106.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:29 UTC | Exercise / conversionRestricted Stock Units · Derivative | 886 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006163 · edgar.xml · derivative · entry 4 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,242 Underlying: Common Stock · 886 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted 3,545 restricted stock units, vesting at 25% on each 1st of May thereafter. F2 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted 3,545 restricted stock units, vesting at 25% on each 1st of May thereafter. Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:29 UTC | Tax withholdingCommon Stock | 376 | $106.50 | $40,044.00 |
DisclosureSEC source: 0001179110-18-006163 · edgar.xml · nonDerivative · entry 2 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510 Read SEC document |
|
| May 01, 2018 Filed May 3, 2018 20:29 UTC | Exercise / conversionCommon Stock | 886 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-006163 · edgar.xml · nonDerivative · entry 1 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
|
| April 23, 2018 Filed Apr 25, 2018 16:51 UTC |
Winssinger Frederic JDirector
|
GrantRestricted Stock Unit · Derivative | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005866 · edgar.xml · derivative · entry 1 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Underlying: Common Stock · 1,128 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 16:50 UTC |
Peng FengDirector
|
GrantRestricted Stock Unit · Derivative | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005865 · edgar.xml · derivative · entry 1 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Underlying: Common Stock · 1,128 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 16:50 UTC |
FULLER GILBERT ADirector
|
GrantRestricted Stock Unit · Derivative | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005864 · edgar.xml · derivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Underlying: Common Stock · 1,128 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 16:50 UTC |
AUCIAUX ROBERTDirector
|
GrantRestricted Stock Unit · Derivative | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005863 · edgar.xml · derivative · entry 1 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Underlying: Common Stock · 1,128 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the last day of the calendar quarter for the next four quarters beginning on June 30, 2018. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 16:49 UTC |
Nixon J ScottDirector
|
GrantRestricted Stock Unit · Derivative | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005862 · edgar.xml · derivative · entry 1 Nixon J Scott · CIK 0001709352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Underlying: Common Stock · 1,128 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the last day of each calendar quarter for the next four quarter beginning on June 30, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the last day of each calendar quarter for the next four quarter beginning on June 30, 2018. Read SEC document |
| April 03, 2018 Filed Apr 4, 2018 21:51 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 40,000 | $86.23 | $3,449,196.00 |
DisclosureSEC source: 0001179110-18-005426 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,214,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $85.60 to $87.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 03, 2018 Filed Apr 4, 2018 21:51 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 40,000 | $86.23 | $3,449,196.00 |
DisclosureSEC source: 0001179110-18-005425 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,214,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $85.60 to $87.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 02, 2018 Filed May 3, 2018 20:30 UTC |
WENTZ MYRON WDirector
|
GiftCommon Stock | 11,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006166 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,202,153 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| April 02, 2018 Filed May 3, 2018 20:30 UTC |
Gull Global Ltd10% owner
|
GiftCommon Stock | 11,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006165 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202,153 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:07 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 40,000 | $80.67 | $3,226,840.00 |
DisclosureSEC source: 0001179110-18-004396 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,254,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $80.50 to $81.25, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:07 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 40,000 | $80.67 | $3,226,840.00 |
DisclosureSEC source: 0001179110-18-004395 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,254,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $80.50 to $81.25, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 12, 2018 Filed Mar 12, 2018 22:31 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 67,464 | $80.84 | $5,453,938.18 |
DisclosureSEC source: 0001179110-18-004089 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,294,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $80.50 to $81.15, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 12, 2018 Filed Mar 12, 2018 22:31 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 67,464 | $80.84 | $5,453,938.18 |
DisclosureSEC source: 0001179110-18-004088 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,294,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $80.50 to $81.15, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 22:31 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 78,129 | $81.19 | $6,343,168.50 |
DisclosureSEC source: 0001179110-18-004089 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,361,517 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $81.00 to $81.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 22:31 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 78,129 | $81.19 | $6,343,168.50 |
DisclosureSEC source: 0001179110-18-004088 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,361,517 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $81.00 to $81.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 82,407 | $81.24 | $6,694,645.79 |
DisclosureSEC source: 0001179110-18-004089 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,439,646 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $81.00 to $81.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 82,407 | $81.24 | $6,694,645.79 |
DisclosureSEC source: 0001179110-18-004088 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,439,646 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $81.00 to $81.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 14,000 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-18-004087 · edgar.xml · derivative · entry 3 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
SaleCommon Stock | 10,696 | $81.00 | $866,376.00 |
DisclosureSEC source: 0001179110-18-004087 · edgar.xml · nonDerivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionCommon Stock | 10,696 | $19.12 | $204,454.04 |
DisclosureSEC source: 0001179110-18-004087 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| March 07, 2018 Filed Mar 7, 2018 23:08 UTC | Exercise / conversionStock - Settles Stock Appreciation Right · Derivative | 20,000 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-003793 · edgar.xml · derivative · entry 3 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 20,000 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| March 07, 2018 Filed Mar 7, 2018 23:08 UTC | SaleCommon Stock | 2,423 | $81.05 | $196,389.00 |
DisclosureSEC source: 0001179110-18-003793 · edgar.xml · nonDerivative · entry 2 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $81.05. Price range in multiple transactions was $81.00 to $81.10 inclusively. Read SEC document |
|
| March 07, 2018 Filed Mar 7, 2018 23:08 UTC | Exercise / conversionCommon Stock | 2,423 | $70.75 | $171,415.14 |
DisclosureSEC source: 0001179110-18-003793 · edgar.xml · nonDerivative · entry 1 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
|
| March 02, 2018 Filed Mar 6, 2018 01:18 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 28,050 | $76.14 | $2,135,797.13 |
DisclosureSEC source: 0001179110-18-003547 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,522,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $75.40 to $77.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 28,050 | $76.14 | $2,135,797.13 |
DisclosureSEC source: 0001179110-18-003546 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,522,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $75.40 to $77.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 01:18 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 11,950 | $75.77 | $905,482.57 |
DisclosureSEC source: 0001179110-18-003547 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,550,103 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $75.25 to $76.50, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 11,950 | $75.77 | $905,482.57 |
DisclosureSEC source: 0001179110-18-003546 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 11,550,103 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $75.25 to $76.50, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 15, 2018 Filed Feb 15, 2018 23:31 UTC |
Noot WalterChief Information Officer
|
Exercise / conversionStock-Settles Stock appreciation Right · Derivative | 16,000 | $0.00 Strike: $62.20 | $0.00 |
DisclosureSEC source: 0001179110-18-002202 · edgar.xml · derivative · entry 3 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 16,000 shares Expires 2022-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.